ADIAL PHARMACEUTICALS INC's ticker is ADILW and the CUSIP is 00688A114. A total of 3 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $88 | -84.8% | 15,606 | 0.0% | 0.00% | – |
| Q1 2023 | $578 | +28.4% | 15,606 | -13.3% | 0.00% | – |
| Q4 2022 | $450 | -55.0% | 18,006 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 18,006 | +140.2% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 7,495 | +130.3% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 3,255 | -24.3% | 0.00% | – |
| Q3 2021 | $3,000 | -50.0% | 4,300 | -51.2% | 0.00% | – |
| Q2 2021 | $6,000 | +200.0% | 8,806 | +95.5% | 0.00% | – |
| Q1 2021 | $2,000 | – | 4,504 | +618.3% | 0.00% | – |
| Q3 2019 | $0 | – | 627 | -51.9% | 0.00% | – |
| Q2 2019 | $0 | – | 1,304 | +552.0% | 0.00% | – |
| Q1 2019 | $0 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS Group AG | 9,502 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |